Erratum: Corrigendum to ‘Synthesis of (2R,8′S,3′E)-δ-tocodienol, a tocoflexol family member designed to have a superior pharmacokinetic profile compared to δ-tocotrienol’ (Tetrahedron (2016) 72(27–28) (4001–4006))

Xingui Liu, Satheesh Gujarathi, Xuan Zhang, Lijian Shao, Marjan Boerma, Cesar M. Compadre, Peter A. Crooks, Martin Hauer-Jensen, Daohong Zhou, Guangrong Zheng

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that the following statement was omitted from the Acknowledgements section of the above published article: The University of Arkansas for Medical Sciences and Drs. G.Z., M.H.-J., P.A.C., and C.M.C. have financial interests in (2R,8′S,3′E)-δ-tocodienol discussed in this report. These financial interests have been reviewed and approved in accordance with the university's conflict of interest policies. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Pages (from-to)5943
Number of pages1
JournalTetrahedron
Volume72
Issue number39
DOIs
StatePublished - 2016
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Erratum: Corrigendum to ‘Synthesis of (2R,8′S,3′E)-δ-tocodienol, a tocoflexol family member designed to have a superior pharmacokinetic profile compared to δ-tocotrienol’ (Tetrahedron (2016) 72(27–28) (4001–4006))'. Together they form a unique fingerprint.

Cite this